Review
Aug 2026
CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria
This study investigates the CRISPR-Cas framework’s potential as a cutting-edge tactic to fight antimicrobial resistance, and finds that the efficiency of CRISPR-Cas is diminished in some bacterial strains due to variations in their CRISPR loci.
Akmal Zubair, M. Hemal, Alaeldeen Ahmed et al.
· Archives of Microbiology · 0 citations